已收录 268921 条政策
 政策提纲
  • 暂无提纲
The CRIPSR/Cas gene-editing system—an immature but useful toolkit for experimental and clinical medicine
[摘要] A Chinese scientist, Jiankui He, and his creation of the world's first genetically altered baby made headlines recently. As a newly developed gene‐editing technique, the CRISPR/Cas system should not be applied to human beings for reproductive pur‐ poses until it has been extensively tested. However, numerous experimental research studies in human somatic, germline cells, and even in embryos, have been conducted, which have shown CRISPR/Cas to be a useful tool for human genome editing and a potential therapeutic method for future clinical use.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 机械工程学
[关键词] CRISPR‐Cas;gene editing;gene therapy;human embryos;recombinant DNA [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文